SCHEMBL26259706

SCHEMBL26259706

CC(C)(C)c1cc(-c2ccco2)c2cc(C(C)(C)C)cc(-c3ccco3)c2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IMPDH2 P12268 1/20 0.37
▸ IMPDH1 P20839 1/20 0.37
▸ ALDH1A1 P00352 5/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ KDM4E B2RXH2 4/20 0.36
▸ NPC1 O15118 4/20 0.36
▸ RAB9A P51151 4/20 0.36
▸ HPGD P15428 3/20 0.36
▸ POLB P06746 2/20 0.36
▸ CACNA1B Q00975 2/20 0.36
▸ APBA1 Q02410 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ TDP1 Q9NUW8 2/20 0.36
▸ USP2 O75604 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ THRB P10828 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26259540 0.80 IMPDH2 (0.34) IMPDH2IMPDH1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL16589090 0.77 ALDH1A1 (0.36) IMPDH2IMPDH1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL14200239 0.77 TAAR1 (0.44) ALDH1A1KDM4ENPC1RAB9AHPGD
SCHEMBL14702250 0.74 PTPN1 (0.40) IMPDH2IMPDH1ALDH1A1SMN1; SMN2CACNA1B
SCHEMBL19194156 0.74 IMPDH2 (0.38) IMPDH2IMPDH1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL15003256 0.73 ALDH1A1 (0.33) ALDH1A1SMN1; SMN2KDM4EHPGDMEN1
SCHEMBL26259526 0.73 CFTR (0.36) IMPDH2IMPDH1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL26259831 0.72 ALDH1A1 (0.42) IMPDH2IMPDH1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL20393504 0.72 ALDH1A1 (0.37) IMPDH2IMPDH1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL1622533 0.71 TAAR1 (0.55) ALDH1A1KDM4ENPC1RAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 — — US disclosed
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND NUDC, CCNL2, SPIN3 IMPDH2 4066/4885IMPDH1 3713/4885ALDH1A1 2125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback